These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 30982674)

  • 1. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Inhibitor Metalloproteinase-2·IGF-Binding Protein 7 for the Prediction of Acute Kidney Injury following Cardiac Surgery.
    Xie Y; Guo Q; Yang B; Xie P; Zhang J; Lu W; Ronco C; Jiang G
    Cardiorenal Med; 2024; 14(1):251-260. PubMed ID: 38588650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of biomarker with clinical risk factors for prediction of severe acute kidney injury in critically ill patients.
    Jia L; Sheng X; Zamperetti A; Xie Y; Corradi V; Chandel S; De Cal M; Montin DP; Caprara C; Ronco C
    BMC Nephrol; 2020 Dec; 21(1):540. PubMed ID: 33302892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study.
    Licheng ; Jia H; Jiang Y; Li W
    BMC Nephrol; 2024 May; 25(1):153. PubMed ID: 38702662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
    Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
    BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers.
    Di Leo L; Nalesso F; Garzotto F; Xie Y; Yang B; Virzì GM; Passannante A; Bonato R; Carta M; Giavarina D; Gregori D; Brendolan A; Ferrari F; Ronco C
    Blood Purif; 2018; 45(1-3):270-277. PubMed ID: 29478052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
    Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
    PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of patients' clinical features at intensive care unit admission on performance of cell cycle arrest biomarkers in predicting acute kidney injury.
    Yang B; Xie Y; Garzotto F; Ankawi G; Passannante A; Brendolan A; Bonato R; Carta M; Giavarina D; Vidal E; Gregori D; Ronco C
    Clin Chem Lab Med; 2020 Sep; 59(2):333-342. PubMed ID: 32986608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
    Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
    Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Renal Stress/Damage and Filtration Biomarkers with Subsequent AKI during Hospitalization among Patients Presenting to the Emergency Department.
    Kimmel M; Shi J; Latus J; Wasser C; Kitterer D; Braun N; Alscher MD
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):938-946. PubMed ID: 27026519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of urinary TIMP-2 and IGFBP7 as potential predictor of acute kidney injury requiring renal replacement therapy and patients' outcome following complex endovascular and open thoracic abdominal aortic aneurysm surgery - a prospective observational study.
    Gombert A; Kotelis D; Rückbeil MV; Barbati M; Martin L; Marx G; Grommes J; Jacobs MJ; Schälte G
    Vasa; 2021 Feb; 50(2):101-109. PubMed ID: 32815460
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery.
    Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X
    BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.